P/E ratio for DaVita (DVA)
P/E ratio as of April 2024 (TTM): 25.7
According to DaVita's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 25.6822. At the end of 2022 the company had a P/E ratio of 12.5.
P/E ratio history for DaVita from 2001 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 12.5 | 1.86% |
| 2021 | 12.3 | -32.76% |
| 2020 | 18.2 | 30.72% |
| 2019 | 13.9 | -77.24% |
| 2018 | 61.3 | 197.62% |
| 2017 | 20.6 | 39.47% |
| 2016 | 14.8 | -73.11% |
| 2015 | 54.9 | 147.85% |
| 2014 | 22.1 | 5.37% |
| 2013 | 21.0 | 5.73% |
| 2012 | 19.9 | 32.95% |
| 2011 | 15.0 | -14.14% |
| 2010 | 17.4 | 21.27% |
| 2009 | 14.4 | 3.43% |
| 2008 | 13.9 | -10.8% |
| 2007 | 15.6 | -23.65% |
| 2006 | 20.4 | -8.21% |
| 2005 | 22.2 | 26.98% |
| 2004 | 17.5 | 17.06% |
| 2003 | 14.9 | 27.8% |
| 2002 | 11.7 | -27.78% |
| 2001 | 16.2 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Universal Health Services
UHS | 16.7 | -34.78% | 🇺🇸 USA |
 LabCorp LH | 27.0 | 5.15% | 🇺🇸 USA |
 Tenet Healthcare THC | 20.7 | -19.36% | 🇺🇸 USA |
 Pediatrix Medical Group MD | 8.01 | -68.82% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.